Hydration effects on the efficacy of the Epidermal growth factor receptor kinase inhibitor afatinib.

Abstract excerpt

Small molecules targeting the EGFR tyrosine kinase domain have been used with some success at treating patients with non-small cell lung cancer driven by activating mutations in the kinase domain. The initial class of inhibitors displaced ATP noncovalently but were rendered ineffective due to the development of resistance mutations in the kinase domain. These were overcome by the development of covalent...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Afatinib
• Share to Binding Sites